HomeNewsBusinessCOVID-19 update | Maharashtra reports 25,425 cases, over 10,000 fewer than day before

COVID-19 update | Maharashtra reports 25,425 cases, over 10,000 fewer than day before

The state's COVID-19 case tally rose to 76,30,606 and death toll reached 1,42,358.

January 27, 2022 / 22:32 IST
Story continues below Advertisement
Representative image
Representative image

Maharashtra on Thursday recorded 25,425 new coronavirus cases, a drop of more than 10,000 compared to the previous day, and 42 deaths, the state health officials said. The new cases included 72 Omicron infections.

The state's COVID-19 case tally rose to 76,30,606 and death toll reached 1,42,358. The case fatality rate stands at 1.86 per cent.On Wednesday, the state had recorded 35,756 cases and 79 fatalities.

Story continues below Advertisement

ALSO READ: COVID-19 update | Mumbai's cases drop to 1,384; 12 die, active tally below 20,000

With 36,708 patients discharged in the last 24 hours, the number of recovered patients rose to 71,97,001. The recovery rate stood at 94.32 per cent.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show